Status:
COMPLETED
VANOS Cream and Skin Barrier Function
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
Medicis Pharmaceutical Corporation
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine the effect of short-term therapy using "VANOS Cream," a super-potent topical steroid cream on skin barrier function in patients with atopic dermatitis. This c...
Eligibility Criteria
Inclusion
- Diagnosis of AD according to Hanifin-Rajka criteria (see Appendix B)
- Age 12 years or older
- Must have an Investigator's Global Assessment (IGA) Score of Moderate, Severe, or Very Severe (See Appendix C)
- Must have failed to achieve adequate disease despite adequate topical or systemic therapy
- Must be a candidate, according to the principal investigator and standard of care, for a super-potent topical steroid course. Subjects that are candidates for super-potent topical steroids are defined as subjects whose disease is not adequately controlled with medium-potency topical steroids or systemic therapy, including phototherapy.
Exclusion
- Active skin infection
- Hypersensitivity to any ingredients in Vanos cream
- Previous use of super-potent topical steroids within 2 weeks of starting study (Class I steroid).
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 21 2010
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00819507
Start Date
January 1 2009
End Date
June 21 2010
Last Update
July 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University Department of Dermatology
Portland, Oregon, United States, 97239